2079B |
Fentanyl and Metabolite, Blood |
2079FL |
Fentanyl and Metabolite, Fluid |
2079SP |
Fentanyl and Metabolite, Serum/Plasma |
2079TI |
Fentanyl and Metabolite, Tissue |
2079U |
Fentanyl and Metabolite, Urine |
8030B |
Drug Facilitated Crime Panel, Blood (Forensic) |
8030SP |
Drug Facilitated Crime Panel, Serum/Plasma (Forensic) |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9176B |
Fentanyl and Metabolite Screen, Blood |
9176FL |
Fentanyl and Metabolite Screen, Fluid |
9176SP |
Fentanyl and Metabolite Screen, Serum/Plasma |
9176TI |
Fentanyl and Metabolite Screen, Tissue |
9291H |
Fentanyl Screen, Hair |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |